1-4 of 4
Lawrence Garbo, MD
Close
Sort by
Journal Articles

Relationship Between Chelation and Clinical Outcomes in Lower-Risk Patients with Myelodysplastic Syndrome (MDS): Registry Analysis at 5 Years

Roger M. Lyons, MD, Billie J. Marek, MD, Carole Paley, MD, Jason Esposito, MSHS, Katie McNamara, MSHS, CCRA, Lawrence Garbo, MD, Nicholas DiBella, MD, Guillermo Garcia-Manero, MD
Journal: Blood
Blood (2014) 124 (21): 1350.
https://doi.org/10.1182/blood.V124.21.1350.1350
Published: 2014
Journal Articles

48-Month Update On Survival and AML Transformation In a 600-Patient Registry Of Lower-Risk MDS Patients

Roger M. Lyons, MD, Billie J. Marek, MD, Carole S. Paley, MD, Jason Esposito, MSHS, Katie McNamara, MSHS, CCRA, Lawrence Garbo, MD, Nicholas DiBella, MD, Guillermo Garcia-Manero, MD
Journal: Blood
Blood (2013) 122 (21): 2775.
https://doi.org/10.1182/blood.V122.21.2775.2775
Published: 2013
Journal Articles

Relationship Between Chelation and Clinical Outcomes in 600 Lower-Risk MDS Patients: Registry Analysis At 36 Months

Roger M. Lyons, MD, Billie J. Marek, MD, Carole Paley, MD, Jason Esposito, MSHS, Lawrence Garbo, MD, Nicholas DiBella, MD, Guillermo Garcia-Manero, MD
Journal: Blood
Blood (2012) 120 (21): 3800.
https://doi.org/10.1182/blood.V120.21.3800.3800
Published: 2012
Journal Articles

24-Month Analysis of the Impact of Chelation on Clinical Outcomes in a 600 Patient Registry of Lower-Risk MDS Patients

Roger M. Lyons, MD, Billie J. Marek, Surabhi Sharma, Carole Paley, Jason Esposito, Lawrence Garbo, MD, Nicholas DiBella, Guillermo Garcia-Manero
Journal: Blood
Blood (2011) 118 (21): 2800.
https://doi.org/10.1182/blood.V118.21.2800.2800
Published: 2011